Objectives: To assess HIV-1 diversity, transmission dynamics and prevalence of transmitted drug resistance (TDR) in Angola, five years after ART scale-up. Methods: Population sequencing of the pol gene was performed on 139 plasma samples collected in 2009 from drug-naive HIV-1 infected individuals living in Luanda. HIV-1 subtypes were determined using phylogenetic analysis. Drug resistance mutations were identified using the Calibrated Population Resistance Tool (CPR). Transmission networks were determined using phylogenetic analysis of all Angolan sequences present in the databases. Evolutionary trends were determined by comparison with a similar survey performed in 2001. Results: 47.1 % of the viruses were pure subtypes (all except B), 47...
Introduction: The surveillance and characterization of the HIV transmission patterns, with or witho...
Unlike the pandemic form of HIV-1 (group M), group O viruses are endemic in west central Africa, esp...
BACKGROUND: Drug resistance transmission in newly diagnosed, drug-naïve HIV-1 infected individuals h...
Objectives To assess HIV-1 diversity, transmission dynamics and prevalence of transmitted drug resi...
<div><p>Objectives</p><p>To assess HIV-1 diversity, transmission dynamics and prevalence of transmit...
HIV-1 genetic diversity and drug resistance mutations (DRMs) remain a public health concern mainly i...
Characterization of HIV-1 subtype diversity in regions where vaccine trials are conducted is critica...
Angola borders and has long-term links with Democratic Republic of Congo (DRC) as well as high level...
Up until 10 years ago, basic and clinical HIV-1 research was mainly performed on HIV-1 subtype B tha...
Background: Angola borders and has long‐term links with Democratic Republic of Congo (DRC) and Repub...
Angola presents a very complex HIV-1 epidemic characterized by the co-circulation of several HIV-1 g...
Copyright © 2011 Saı̈dou Mamadou et al. This is an open access article distributed under the Creativ...
Objective: To assess the mutational patterns and factors associated with baseline drug-resistant HIV...
Copyright © 2015 Carmen Andréa F. Lopes et al.This is an open access article distributed under theC...
Texto completo: acesso restrito. p. 2066–2072The extraordinary genetic diversity and immune evasion ...
Introduction: The surveillance and characterization of the HIV transmission patterns, with or witho...
Unlike the pandemic form of HIV-1 (group M), group O viruses are endemic in west central Africa, esp...
BACKGROUND: Drug resistance transmission in newly diagnosed, drug-naïve HIV-1 infected individuals h...
Objectives To assess HIV-1 diversity, transmission dynamics and prevalence of transmitted drug resi...
<div><p>Objectives</p><p>To assess HIV-1 diversity, transmission dynamics and prevalence of transmit...
HIV-1 genetic diversity and drug resistance mutations (DRMs) remain a public health concern mainly i...
Characterization of HIV-1 subtype diversity in regions where vaccine trials are conducted is critica...
Angola borders and has long-term links with Democratic Republic of Congo (DRC) as well as high level...
Up until 10 years ago, basic and clinical HIV-1 research was mainly performed on HIV-1 subtype B tha...
Background: Angola borders and has long‐term links with Democratic Republic of Congo (DRC) and Repub...
Angola presents a very complex HIV-1 epidemic characterized by the co-circulation of several HIV-1 g...
Copyright © 2011 Saı̈dou Mamadou et al. This is an open access article distributed under the Creativ...
Objective: To assess the mutational patterns and factors associated with baseline drug-resistant HIV...
Copyright © 2015 Carmen Andréa F. Lopes et al.This is an open access article distributed under theC...
Texto completo: acesso restrito. p. 2066–2072The extraordinary genetic diversity and immune evasion ...
Introduction: The surveillance and characterization of the HIV transmission patterns, with or witho...
Unlike the pandemic form of HIV-1 (group M), group O viruses are endemic in west central Africa, esp...
BACKGROUND: Drug resistance transmission in newly diagnosed, drug-naïve HIV-1 infected individuals h...